Effect of desialylation on binding, affinity, and specificity of 56 monoclonal antibodies against MUC1 mucin

Tumor Biology

Volumn 19, Issue SUPPL.1, 1997, Pages 100-110

  Dai, Jian ^a   Jeffrey Allard, W ^a   Davis, Gary ^a   Yeung, Kwok K ^a  

^a BAYER CORPORATION   (United States)

Author keywords

Antibody specificity; Desialylation; Epitope; MUC1 mucin

Indexed keywords

MONOCLONAL ANTIBODY; MUCIN;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; BINDING AFFINITY; COMPETITIVE INHIBITION; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; GENETIC POLYMORPHISM; GLYCOSYLATION; NONHUMAN; PRIORITY JOURNAL; SIALYLATION; TANDEM REPEAT; TARGET CELL;

EID: 6844253866     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056510     Document Type: Conference Paper

References (22)

1. Eskimo HT, Kufe D: Purification and characterization of a high molecular weight glycoprotein detected in milk and breast carcinomas. J Immunol 1985;135:3610-3615.
2. Hilkens J, Buijs F, Lightenberg SV: Complexity of MAM-6, an epithelial sialomucin associated with carcinomas. Cancer Res 1989;49:786-793.
3. Gendler SJ, Spicer AP, Lalani EN, Duhig T, Peat N, Burchell J, Pemberton L, Boshell M, Taylor-Papadimitriou J: Structure and biology of a carcinoma-associated mucin, MUC1, Am Rev Respir Dis 1991; 144:542-847.
4. Hayes DF, Sekine H, Marcus D, Alper CA, Kufe DW: Genetically determined polymorphism of the circulating human breast cancer-associated DF3 antigen. Blood 1988; 71:436-440.
5. Hayes DF, Sekine H, Ohno T, Abe ME, Keefe K, Kufe DW: Use of a murine MAb for detection of circulating plasma DF3 antigen levels in breast cancer patients J Clin Invest 1985;75:1671-1678.
6. Hayes DF, Zurawski VR Jr, Kufe DW: Comparison of circulating CA 15-3 and carcinoembryonic antigen levels in patients with breast cancer. J Clin Oncol 1986;4:1542-1550.
7. Eskelinen M, Tikanoja S, Valkamo E, Loikknen M, Collan Y: Cancer-associated antigen CA 15-3 in the diagnostics of breast tumours. Scand J Clin Lab Invest 1988;48: 653-658.
8. McGukin MA, Devine PL, Ramm LE, Ward BG: Factors effecting the measurement of tumor-associated MUC1 mucins in serum. Tumor Biol 1994;15:33-44.
9. Kufe D, Inghirami G, Abe M, Hayes D, Justi-Wheeler H, Schlom J: Dif- ferential reactivity of a novel MAb (DF3) with human malignant versus benign breast tumors. Hybrid 1984; 3:223-232.
10. Hilkens J, Buijs F, Hilgers J, Hageman P, Calafat J, Sonnenberg A, van der Valk M: Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int J Cancer 1984; 34:197-206.
11. Burchell J, Gendler S, Taylor-Papadimitriou J, Girling A, Lewis A, Millis R, Lamport D: Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res 1987; 47:5476-5482.
12. Reddish MA, Helerecht N, Almeida AF, Madiyalakan R, Suresh MR, Longenecker BM: Epitope mapping of MAb B27.29 within the peptide core of the malignant breast carcinoma-associated mucin antigen coded for by the human MUC1 gene. J Tumor Marker Oncol 1992;7:19-27.
13. Ho JJL, Cheng S, Kim YS: Access to peptide regions of a surface mucin (MUC1) is reduced by sialic acids. Biochem Biophy Res Commun 1995;210:866-873.
14. Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, Duhig T, Peat N, Burchell J, Pemberton L, Lalani EN, Wilson D: Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem 1990;265:15286-15293.
15. Devine PL, McGuckin MA, Ward BG: Circulating mucins as tumor markers in ovarian cancers. Antiancer Res 1992;12:709-718.
16. Baeckström D, Nilsson O, Price MR, Lindholm L, Hansson G: Discrimination of MUC-1 mucins from other sialyl Lea carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody. Cancer Res 1993;53:755-761.
17. Percy L, Hayes DF, Maimonis P, Abe M, O'Hara C, Kufe DW: Tumor-selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen. Cancer Res 1992;52:2563-2568.
18. Price MR, Hudecz F, O'Sullivan C, Baldwin RW, Edwards PM, Tendler SJB: Immunological and structural features of the protein core of human polymorphic epithelial mucin. Mol Immunol 1990;27:795-802.
19. Burchell J, Taylor-Papadimitriou J, Boshell M, Gendler S, Duhig T: A short sequence within the amino acid tandem repeat of a cancer-associated mucin contains immuno-dominant epitopes. Int J Cancer 1989;44:691-696.
20. Apostolopoulos V, Xing PX, Trapani JA, McKenzie IF: Production of anti-breast cancer monoclonal antibodies using a glutathione-S-transferase-MUC1 bacterial fusion protein. Br J Cancer 1993;67:713-720.
21. Xing PX, Prenzoska J, Quelch K, McKenzie IF: Second-generation anti-MIJCI peptide monoclonal antibodies. Cancer Res 1992;52:2310-2317.
22. Xing PX, Prenzoska J, McKenzie IF: Epitope mapping of anti-breast and anti-ovarian mucin monoclonal antibodies. Mol Immunol 1992;29: 645-650.